← Back to Search

Shared Decision Making Tool for Managing Adolescent Behaviors

N/A
Recruiting
Research Sponsored by Seattle Children's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Children between the ages of 11 and 17
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 weeks post-baseline, 3 months post-baseline
Awards & highlights

Study Summary

This trial will test how well a new tool can help people manage their health: it's effectiveness & how easy it is to use.

Who is the study for?
This trial is for English-speaking parents or guardians and their children aged between 11 and 17. Both the child and parent/guardian must be willing to participate together as a pair, known as dyads.Check my eligibility
What is being tested?
The study is testing a new tool called the Media Discussion and Planning Tool (MDPT) designed to help families manage media use. It's a pilot randomized controlled trial, meaning participants are randomly chosen to either use MDPT or not, to see how effective it is.See study design
What are the potential side effects?
Since this intervention involves discussion and planning rather than medication, there aren't typical medical side effects. However, participants may experience changes in family dynamics or stress related to altering media habits.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 11 and 17 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 weeks post-baseline, 3 months post-baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 weeks post-baseline, 3 months post-baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Adolescent Media Rule Engagement
Change in Problematic Media use
Secondary outcome measures
Decision and goal setting
Feasibility and acceptability of MDPT
Implementation Readiness
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MDPTExperimental Treatment1 Intervention
Families randomized to the intervention condition will receive the MDPT after they complete the baseline survey.
Group II: Delayed MDPTActive Control1 Intervention
Families assigned to the control condition will receive the MDPT after study completion.

Find a Location

Who is running the clinical trial?

Seattle Children's HospitalLead Sponsor
302 Previous Clinical Trials
5,216,707 Total Patients Enrolled
4 Trials studying Adolescent Behaviors
898 Patients Enrolled for Adolescent Behaviors

Media Library

Media Discussion and Planning Tool (MDPT) Clinical Trial Eligibility Overview. Trial Name: NCT05722535 — N/A
Adolescent Behaviors Research Study Groups: Delayed MDPT, MDPT
Media Discussion and Planning Tool (MDPT) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05722535 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants currently being sought for this experiment?

"Per the information provided on clinicaltrials.gov, this trial is not currently taking in new participants. It was originally posted on June 1st 2023 and last updated February 1st 2023. However, 55 other trials are actively enrolling patients at present."

Answered by AI

What effects is this clinical trial hoping to bring about?

"The primary metric of this trial is Change in Problematic Media Use, which will be tracked over Baseline, 3 weeks post-Baseline, and 3 months post-Baseline time frames. Additionally, Decision Making & Goal Setting (feeling informed about risks/clarity on what matters most), Within Family Communication (autonomy supportive parenting/parent-adolescent communication) and Feasibility & Acceptability of MDPT are also calculated as secondary outcomes."

Answered by AI
~109 spots leftby Apr 2025